tetrabenazine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daniels, AJ; Diliberto, EJ; Reinhard, JF; Viveros, OH | 1 |
| Daniels, AJ; Reinhard, JF; Viveros, OH | 1 |
| Del Zompo, M; Gessa, GL; Piccardi, MP; Quartu, M; Ruiu, S; Vaccari, A | 1 |
| DaSilva, JN; Domino, EF; Kilbourn, MR | 1 |
| Frey, K; Kilbourn, M | 1 |
| Agid, Y; Duyckaerts, C; Faucheux, B; Hauw, JJ; Herrero, MT; Hirsch, EC; Obeso, JA; Villares, J | 1 |
| Kilbourn, MR; Kuszpit, K; Sherman, P | 1 |
| Hogan, KA; Sonsalla, PK; Staal, RG | 1 |
| German, DC; Lane, K; Liang, CL; Manaye, KF; Sonsalla, PK | 1 |
| He, XJ; Nakayama, H; Shibui, Y; Uchida, K | 1 |
| Chan, MH; Chao, KT; Chen, ZA; Ee, TW; Hsiao, IT; Hsu, CH; Kung, MP; Lin, KJ; Weng, CC; Wey, SP; Yen, TC | 1 |
11 other study(ies) available for tetrabenazine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Adrenal Medulla; Animals; Calcium; Catecholamines; Cattle; Cell Compartmentation; Cells, Cultured; Desipramine; Digitonin; Drug Interactions; Nicotine; Pyridines; Pyridinium Compounds; Subcellular Fractions; Tetrabenazine; Tyrosine 3-Monooxygenase | 1987 |
Potentiation by reserpine and tetrabenazine of brain catecholamine depletions by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in the mouse; evidence for subcellular sequestration as basis for cellular resistance to the toxicant.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Catecholamines; Corpus Striatum; Cytoplasmic Granules; Dopamine; Drug Interactions; Hippocampus; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Pyridines; Reserpine; Subcellular Fractions; Tetrabenazine | 1988 |
Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Biomarkers; Brain; Corpus Striatum; Dopamine; Dopamine Agents; In Vitro Techniques; Male; Mice; Microscopy, Electron; MPTP Poisoning; Nervous System Diseases; Pyridinium Compounds; Synaptic Vesicles; Tetrabenazine | 1993 |
In vivo imaging of monoaminergic nerve terminals in normal and MPTP-lesioned primate brain using positron emission tomography (PET) and [11C]tetrabenazine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biogenic Monoamines; Brain; Carbon Radioisotopes; Female; Macaca nemestrina; Male; Nerve Endings; Reference Values; Tetrabenazine; Tomography, Emission-Computed | 1993 |
Striatal concentrations of vesicular monoamine transporters are identical in MPTP-sensitive (C57BL/6) and -insensitive (CD-1) mouse strains.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Binding Sites; Carbon Radioisotopes; Corpus Striatum; Female; In Vitro Techniques; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Neuropeptides; Neurotransmitter Agents; Protein Binding; Radioactive Tracers; Radioligand Assay; Tetrabenazine; Tissue Distribution; Tritium; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 1996 |
[125I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Aged, 80 and over; Animals; Basal Ganglia; Brain Diseases; Dopamine Agents; Epidermal Growth Factor; ErbB Receptors; Female; Humans; Immunohistochemistry; Iodine Radioisotopes; Macaca fascicularis; Male; Parkinson Disease; Supranuclear Palsy, Progressive; Tetrabenazine | 1998 |
Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Carbon Radioisotopes; Carrier Proteins; Cerebellum; Cerebral Cortex; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Hippocampus; Hypothalamus; Kinetics; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neuropeptides; Neurotransmitter Agents; Radioligand Assay; Tetrabenazine; Tissue Distribution; Tritium; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2000 |
Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dopamine Agents; Histological Techniques; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Neuropeptides; Synaptic Vesicles; Synaptosomes; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2000 |
Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Animals; Cell Count; Drug Synergism; Locus Coeruleus; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Mice; Nerve Degeneration; Neurons; Neuropeptides; Norepinephrine; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2000 |
MPTP-induced neuroblast apoptosis in the subventricular zone is not regulated by dopamine or other monoamine transporters.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Uptake Inhibitors; Adult Stem Cells; Animals; Apoptosis; Cerebral Ventricles; Desipramine; Dopamine Uptake Inhibitors; Drug Interactions; Fluoxetine; Gene Expression Regulation; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurotoxins; Neurotransmitter Transport Proteins; Piperazines; Selective Serotonin Reuptake Inhibitors; Tetrabenazine | 2009 |
Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biphenyl Compounds; Corpus Striatum; Disease Models, Animal; Fluorine Radioisotopes; Humans; Lignans; Mice; Neurons; Parkinson Disease; Parkinson Disease, Secondary; Positron-Emission Tomography; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2017 |